The nucleic acid detection diagnostics are implicit from the concept of preserving enough genomic nucleotides in all strains to enable their detection by one or at most very few assays. Nucleic acid detection reagents are generally used to detect various viral, bacterial, and targeted drug mutation sequences. It has the privileges of high sensitivity, precise quantification and wide linear range, which considerably shortens the detection interval. In an emergency, pathogens can be detected, which helps with earlier treatment. The detection of nucleic acids by means of mass spectrometry is a high-precision alternative to fluorescence-based method for quantitative and qualitative genome analysis.
Referring to the study, ‘Global Nucleic Acid Detection Reagents Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027‘. Few of the key companies operating in the global nucleic acid detection reagents market include Eiken Chemical, TRUPCR, Enzo Life Sciences, GE Healthcare, Vazyme Biotech Co, Thermo Scientific, Roche, AltaBioscience, Promega Corporation, Maccura, BGI, Sigma-Aldrich and among others. Various well-organized companies are focusing on numerous organic growth strategies such as product approvals, product launches and others for instance patents & events. These strategic activities paved the manner for the expansion of the business & customer base of market players. The contributors of the Nucleic Acid Detection Reagents market are expected to provide profitable growth opportunities in the future with the increasing demand for the Nucleic Acid Detection Reagents in the global market.
Based on type, nucleic acid detection reagents market has been bifurcated as Ligase Chain Reaction (LCR) and Polymerase Chain Reaction (PCR). LCR is a DNA amplification method that differs from the PCR in that it engages a thermostable ligase for joining two probes or other molecules together which can then be augmented by standard PCR cycling. Additionally, PCR is a laboratory method used to amplify the DNA sequences. The method uses short sequences of deoxyribonucleic acid (DNA) called primers to select the segment of the genome to amplify. This technique generates various copies of the target progression in just a few hours. Moreover, in terms of applications, nucleic acid detection reagents market has been categorized as meat speciation testing, disease detection (new coronavirus/H1N1/ebola virus etc), food & drink field and others.
Rise in the numbers of various infectious diseases, followed by growth in advancement in nanotechnology & nanomaterials, rise in incidences of genetic diseases and increase in concern to monitor the disease treatment are some major factors, which are responsible for growth of the nucleic acid detection reagents market. Apart from this, limited amount of target nucleic acid in specimens may impact the market.
Based on regional analysis, the North-America region dominates the global nucleic acid detection reagents market owing to increase in health care expenditure and rapid economic development across the region. The Europe and Asia-Pacific regions are estimated to witness higher growth rate due to growth in technological advancements and increase in research & development (R&D) expenditure over the forecast period.
For More Information, refer to below link:-
Ankur Gupta, Head Marketing & Communications